Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: A pooled analysis of 96 population-based studies with 331 288 participants

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 8, 2015, Pages 624-637

  Danaei, Goodarz ^a   Fahimi, Saman ^a   Lu, Yuan ^a   Zhou, Bin ^b   Hajifathalian, Kaveh ^a   Cesare, Mariachiara Di ^b   Lo, Wei Cheng ^c   Reis Santos, Barbara ^d   Cowan, Melanie J ^e   Shaw, Jonathan E ^f   Bentham, James ^b   Lin, John K ^g   Bixby, Honor ^b   Magliano, Dianna ^f   Bovet, Pascal ^h,ie   Miranda, J Jaime ⁱ   Khang, Young Ho ^j   Stevens, Gretchen A ^e   Riley, Leanne M ^e   Ali, Mohammed K ^k   Ezzati, Majid ^b   Kadir, Khalid Abdul ^l   Abu Rmeileh, Niveen M ^m   Acosta Cazares, Benjamin ⁿ   Aekplakorn, Wichai ^o   Aguilar Salinas, Carlos A ^p   Ahmadvand, Alireza ^q   Nsour, Mohannad Al ^r   Alkerwi, Ala'a ^s   Amouyel, Philippe ^t   Andersen, Lars Bo ^u   Anderssen, Sigmund A ^v   Andrade, Dolores S ^w   Anjana, Ranjit Mohan ^x   Aounallah Skhiri, Hajer ^y   Aris, Tahir ^z   Arlappa, Nimmathota ^aa   Arveiler, Dominique ^ab   Assah, Felix K ^ac   Avdicová, Mária ^ad   Balakrishna, Nagalla ^aa   Bandosz, Piotr ^ae   Barbagallo, Carlo M ^af   Alberto Barcelo ^ag   Batieha, Anwar M ^ah   Baur, Louise A ^ai   Romdhane, Habiba Ben ^aj   Bernabe Ortiz, Antonio ⁱ   Bhargava, Santosh K ^ak   Bi, Yufang ^al   Bjerregaard, Peter ^u,if   Björkelund, Cecilia ^am   Blake, Margaret ^an   Blokstra, Anneke ^ao   Bo, Simona ^ap   Boehm, Bernhard O ^aq   Boissonnet, Carlos P ^ar   Brajkovich, Imperia ^as   Breckenkamp, Juergen ^at   Brewster, Lizzy M ^au   Brian, Garry R ^av   Bruno, Graziella ^ap   Bugge, Anna ^u   de León, Antonio Cabrera ^aw   Can, Gunay ^ax   Cândido, Ana Paula C ^d   Capuano, Vincenzo ^ay   Carvalho, Maria J ^az   Casanueva, Felipe F ^ba   Caserta, Carmelo A ^bb   Castetbon, Katia ^bc   Chamukuttan, Snehalatha ^bd   Chaturvedi, Nishi ^be   Chen, Chien Jen ^bf   Chen, Fangfang ^bg   Chen, Shuohua ^bh   Cheng, Ching Yu ^bi   Chetrit, Angela ^bj   Chiou, Shu Ti ^bk   Cho, Yumi ^bl   Chudek, Jerzy ^bm   Cifkova, Renata ^bn   Claessens, Frank ^bo   Concin, Hans ^bp   Cooper, Cyrus ^bq   Cooper, Rachel ^be   Costanzo, Simona ^br   Cottel, Dominique ^bs   Cowell, Chris ^ai   Crujeiras, Ana B ^bt   D'Arrigo, Graziella ^bu   Dallongeville, Jean ^bs   Dankner, Rachel ^bj   Dauchet, Luc ^bv   de Gaetano, Giovanni ^br   de Henauw, Stefaan ^bw   Deepa, Mohan ^x   Dehghan, Abbas ^bx   Dhana, Klodian ^bx   Di Castelnuovo, Augusto F ^br   Djalalinia, Shirin ^q   Doua, Kouamelan ^by   Drygas, Wojciech ^bz   Du, Yong ^ca   Egbagbe, Eruke E ^cb   Eggertsen, Robert ^am   Ati, Jalila El ^cc   Elosua, Roberto ^cd   Erasmus, Rajiv T ^ce   Erem, Cihangir ^cf   Ergor, Gul ^cg   Eriksen, Louise ^u   Escobedo de la Peña, Jorge ⁿ   Fall, Caroline H ^ch   Farzadfar, Farshad ^q   Felix Redondo, Francisco J ^ci   Ferguson, Trevor S ^cj   Fernández Bergés, Daniel ^ck   Ferrari, Marika ^cl   Ferreccio, Catterina ^cm   Finn, Joseph D ^cn   Föger, Bernhard ^bp   Foo, Leng Huat ^co   Fouad, Heba M ^e   Francis, Damian K ^cj   do Carmo Franco, Maria ^cp   Franco, Oscar H ^bx   Frontera, Guillermo ^cq   Furusawa, Takuro ^cr   Gaciong, Zbigniew ^cs   Galbarczyk, Andrzej ^ct   Garnett, Sarah P ^ai   Gaspoz, Jean Michel ^cu   Gasull, Magda ^cv   Gates, Louise ^cw   Geleijnse, Johanna M ^cx   Ghasemain, Anoosheh ^q   Giampaoli, Simona ^cy   Gianfagna, Francesco ^cz   Giovannelli, Jonathan ^bv   Gross, Marcela Gonzalez ^da   González Rivas, Juan P ^db   Gorbea, Mariano Bonet ^dc   Gottrand, Frederic ^t   Grant, Janet F ^dd   Grodzicki, Tomasz ^ct   Grøntved, Anders ^u   Gruden, Grabriella ^ap   Gu, Dongfeng ^de   Guan, Ong Peng ^df   Guerrero, Ramiro ^dg   Guessous, Idris ^cu   Guimaraes, Andre L ^dh   Gutierrez, Laura ^di   Hardy, Rebecca ^be   Kumar, Rachakulla Hari ^aa   He, Jiang ^dj   Heidemann, Christin ^ca   Hihtaniemi, Ilpo Tapani ^b   Ho, Sai Yin ^dk   Ho, Suzanne C ^dl   Hofman, Albert ^bx   Russo Horimoto, Andrea R V ^dm   Hormiga, Claudia M ^dn   Horta, Bernardo L ^d   Houti, Leila ^do   Hussieni, Abdullatif S ^m   Huybrechts, Inge ^dp   Hwalla, Nahla ^dq   Iacoviello, Licia ^br   Iannone, Anna G ^ay   Ibrahim, Mohsen M ^dr   Ikeda, Nayu ^ds   Ikram, Arfan M ^bx   Irazola, Vilma E ^di   Islam, Muhammad ^dt   Iwasaki, Masanori ^du   Jacobs, Jeremy M ^dv   Jafar, Tazeen ^bi   Jasienska, Grazyna ^ct   Jiang, Chao Qiang ^dk   Jonas, Jost B ^dw   Joshi, Pradeep ^e   Kafatos, Anthony ^dx   Kalter Leibovici, Ofra ^bj   Kasaeian, Amir ^q   Katz, Joanne ^dy   Kaur, Prabhdeep ^dz   Kavousi, Maryam ^bx   Kelishadi, Roya ^ea   Kengne, Andre P ^eb   Kersting, Mathilde ^ec   Khader, Yousef Saleh ^ah   Kiechl, Stefan ^ed   Kim, Jeongseon ^ee   Kiyohara, Yutaka ^ef   Kolsteren, Patrick ^eg   Korrovits, Paul ^eh   Koskinen, Seppo ^ei   Kratzer, Wolfgang ^ej   Kromhout, Daan ^cx   Kula, Krzysztof ^ek   Kurjata, Pawel ^bz   Kyobutungi, Catherine ^el   Lachat, Carl ^bw   Laid, Youcef ^em   Lam, Tai Hing ^dk   Landrove, Orlando ^en   Lanska, Vera ^eo   Lappas, Georg ^ep   Laxmaiah, Avula ^aa   Leclercq, Catherine ^eq   Lee, Jeannette ^er   Lee, Jeonghee ^ee   Lehtimäki, Terho ^es   Rampal, Lekhraj ^et   León Muñoz, Luz M ^eu   Li, Yanping ^a   Lim, Wei Yen ^er   Fernanda Lima Costa, M ^ev   Lin, Hsien Ho ^c   Lin, Xu ^hq   Lissner, Lauren ^am   Lorbeer, Roberto ^ew   Lozano, José Eugenio ^ex   Lundqvist, Annamari ^ei   Lytsy, Per ^ey   Ma, Guansheng ^ez   Machado Coelho, George L L ^d   Machi, Suka ^fa   Maggi, Stefania ^bu   Makdisse, Marcia ^fb   Rao, Kodavanti Mallikharjuna ^aa   Manios, Yannis ^fc   Manzato, Enzo ^fd   Margozzini, Paula ^cm   Marques Vidal, Pedro ^fe   Martorell, Reynaldo ^k   Masoodi, Shariq R ^ff   Matsha, Tandi E ^fg   Mbanya, Jean Claude N ^fh   McFarlane, Shelly R ^cj   McGarvey, Stephen T ^fi   McLachlan, Stela ^fj   McNulty, Breige A ^fk   Mediene Benchekor, Sounnia ^do   Meirhaeghe, Aline ^fl   Menezes, Ana Maria B ^d   Merat, Shahin ^q   Meshram, Indrapal I ^aa   Mi, Jie ^bg   Miquel, Juan Francisco ^cm   Mohamed, Mostafa K ^fm   Mohammad, Kazem ^q   Mohan, Viswanathan ^x   Yusoff, Muhammad Fadhli Mohd ^z   Moller, Niels C ^u   Molnar, Denes ^fn   Mondo, Charles K ^fo   Moreno, Luis A ^fp   Morgan, Karen ^fq   Moschonis, George ^fc   Mossakowska, Malgorzata ^fr   Mostafa, Aya ^fm   Mota, Jorge ^az   Muiesan, Maria L ^fs   Müller Nurasyid, Martina ^ft   Mursu, Jaakko ^fu   Nagel, Gabriele ^fv   Namesna, Jana ^ad   Nang, Ei Ei K ^er   Nangia, Vinay B ^fw   Navarrete Muñoz, Eva Maria ^cv   Ndiaye, Ndeye Coumba ^fl   Nervi, Flavio ^cm   Nguyen, Nguyen D ^fx   Nieto Martínez, Ramfis E ^fy   Ning, Guang ^al   Ninomiya, Toshiharu ^ef   Noale, Marianna ^bu   Noto, Davide ^af   Ochoa Avilés, Angélica M ^w   Oh, Kyungwon ^bl   Onat, Altan ^ax   Osmond, Clive ^ch   Otero, Johanna A ^dn   Palmieri, Luigi ^cy   Panda Jonas, Songhomitra ^ae   Panza, Francesco ^fz   Parsaeian, Mahboubeh ^q   Peixoto, Sergio Viana ^ev   Pereira, Alexandre C ^dm   Peters, Annette ^ft   Peykari, Niloofar ^q   Pilav, Aida ^ga   Pitakaka, Freda ^gb   Piwonska, Aleksandra ^bz   Piwonski, Jerzy ^bz   Plans Rubió, Pedro ^gc   Porta, Miquel ^cd   Portegies, Marileen L P ^bx   Poustchi, Hossein ^q   Pradeepa, Rajendra ^x   Price, Jacqueline F ^fj   Punab, Margus ^eh   Qasrawi, Radwan F ^gd   Qorbani, Mostafa ^ge   Raitakari, Olli ^gf   Rao, Sudha Ramachandra ^dz   Ramachandran, Ambady ^bd   Ramos, Rafel ^gg   Rampal, Sanjay ^gh   Rathmann, Wolfgang ^gi   Redon, Josep ^gj   Reganit, Paul Ferdinand M ^gk   Rigo, Fernando ^gl   Robinson, Sian M ^bq   Robitaille, Cynthia ^gm   Rodríguez, Laura A ^gn   Rodríguez Artalejo, Fernando ^eu   Rodriguez Perez, María del Cristo ^aw   Rojas Martinez, Rosalba ^go   Romaguera, Dora ^gp   Rosengren, Annika ^ep   Rubinstein, Adolfo ^di   Rui, Ornelas ^gq   Ruiz Betancourt, Blanca Sandra ⁿ   Rutkowski, Marcin ^ae   Sabanayagam, Charumathi ^df   Sachdev, Harshpal S ^gr   Saidi, Olfa ^aj   Sakarya, Sibel ^gs   Salanave, Benoit ^bc   Salonen, Jukka T ^gt   Salvetti, Massimo ^fs   Sánchez Abanto, Jose ^gu   dos Santos, Renata Nunes ^gv   Santos, Rute ^az   Sardinha, Luis B ^gw   Scazufca, Marcia ^gv   Schargrodsky, Herman ^gx   Scheidt Nave, Christa ^ca   Shibuya, Kenji ^gy   Shin, Youchan ^df   Shiri, Rahman ^gz   Siantar, Rosalynn ^df   Sibai, Abla M ^dq   Simon, Mary ^bd   Simons, Judith ^ha   Simons, Leon A ^gb   Sjostrom, Michael ^hb   Slowikowska Hilczer, Jolanta ^ek   Slusarczyk, Przemyslaw ^fr   Smeeth, Liam ^hc   Snijder, Marieke B ^au   Solfrizzi, Vincenzo ^fz   Sonestedt, Emily ^hd   Soumare, Aicha ^he   Staessen, Jan A ^bo   Steene Johannessen, Jostein ^v   Stehle, Peter ^hf   Stein, Aryeh D ^k   Stessman, Jochanan ^dv   Stöckl, Doris ^ft   Stokwiszewski, Jakub ^hg   Strufaldi, Maria Wany ^cp   Sun, Chien An ^hh   Sundström, Johan ^ey   Suriyawongpaisal, Paibul ^o   Sy, Rody G ^gk   Tai, E Shyong ^er   Tarawneh, Mohammed ^hi   Tarqui Mamani, Carolina B ^gu   Thijs, Lutgarde ^bo   Tolstrup, Janne S ^u   Topbas, Murat ^cf   Torrent, Maties ^hj   Traissac, Pierre ^hk   Trinh, Oanh T H ^fx   Tulloch Reid, Marshall K ^cj   Tuomainen, Tomi Pekka ^fu   Turley, Maria L ^hl   Tzourio, Christophe ^he   Ueda, Peter ^a   Ukoli, Flora M ^ht   Ulmer, Hanno ^ed   Valdivia, Gonzalo ^cm   van Valkengoed, Irene G M ^hu   Vanderschueren, Dirk ^bo   Vanuzzo, Diego ^hv   Vega, Tomas ^hw   Velasquez Melendez, Gustavo ^hx   Veronesi, Giovanni ^cz   Verschuren, Monique ^ao   Vioque, Jesus ^hy   Virtanen, Jyrki ^fu   Visvikis Siest, Sophie ^fl   Viswanathan, Bharathi ^ie   Vollenweider, Peter ^fe   Voutilainen, Sari ^fu   Wade, Alisha N ^hz   Wagner, Aline ^ia   Walton, Janette ^ib   Mohamud, Wan Nazaimoon Wan ^ic   Wang, Ming Dong ^gm   Wang, Ya Xing ^id   Wannamethee, S Goya ^be   Weerasekera, Deepa ^hl   Whincup, Peter H ^hm   Widhalm, Kurt ^hn   Wiecek, Andrzej ^bm   Wilks, Rainford J ^cj   Willeit, Johann ^ed   Wojtyniak, Bogdan ^hg   Wong, Tien Yin ^bi   Woo, Jean ^dl   Woodward, Mark ^ai,ho   Wu, Aleksander Giwercman ^hd   Wu, Frederick C ^cn   Wu, Shou Ling ^bh   Xu, Haiquan ^hp   Yang, Xiaoguang ^hq   Ye, Xingwang ^hr   Yoshihara, Akihiro ^du   Younger Coleman, Novie O ^cj   Zambon, Sabina ^fd   Zargar, Abdul Hamid ^hs   Zdrojewski, Tomasz ^ae   Zhao, Wenhua ^hq   Zheng, Yingfeng ^df   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF LAUSANNE   (Switzerland)

ⁱ UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^j Seoul National University   (South Korea)

^k EMORY UNIVERSITY   (United States)

^l MONASH UNIVERSITY MALAYSIA   (Malaysia)

^m BIRZEIT UNIVERSITY   (Palestine)

ⁿ INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^o MAHIDOL UNIVERSITY   (Thailand)

^p INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^q TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^r Eastern Mediterranean Public Health Network   (Jordan)

^s LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^t UNIV LILLE   (France)

^u UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^v NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^w UNIVERSIDAD DE CUENCA   (Ecuador)

^x MADRAS DIABETES RESEARCH FOUNDATION   (India)

^y National Institute of Public Health   (Tunisia)

^z MINISTRY OF HEALTH   (Malaysia)

^aa INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^ab Strasbourg University and Hospital   (France)

^ac Health of Population in Transition (HOPIT) Research Group   (Cameroon)

^ad Regional Authority of Public Health   (Slovakia)

^ae MEDICAL UNIVERSITY OF GDANSK   (Poland)

^af UNIVERSITY OF PALERMO   (Italy)

^ag PAN AMERICAN HEALTH ORGANIZATION   (United States)

^ah JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^ai UNIVERSITY OF SYDNEY   (Australia)

^aj UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^ak Sunder Lal Jain Hospital   (India)

^al SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^am UNIVERSITY OF GOTHENBURG   (Sweden)

^an NATIONAL CENTRE FOR SOCIAL RESEARCH   (United Kingdom)

^ao NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ap UNIVERSITY OF TURIN   (Italy)

^aq NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^ar Centro de Educacion Medica e Investigaciones Clinicas   (Argentina)

^as UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^at BIELEFELD UNIVERSITY   (Germany)

^au UNIVERSITY OF AMSTERDAM   (Netherlands)

^av Fred Hollows Foundation New Zealand   (New Zealand)

^aw Canarian Health Service   (Spain)

^ax ISTANBUL UNIVERSITY   (Turkey)

^ay Reparto di Cardiologia ed UTIC di Mercato S   (Italy)

^az UNIVERSITY OF PORTO   (Portugal)

^ba UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^bb Associazione Calabrese di Epatologia   (Italy)

^bc French Institute for Health Surveillance   (France)

^bd India Diabetes Research Foundation   (India)

^be UNIVERSITY COLLEGE LONDON   (United Kingdom)

^bf ACADEMIA SINICA   (Taiwan)

^bg CAPITAL INSTITUTE OF PEDIATRICS   (China)

^bh KAILUAN GENERAL HOSPITAL   (China)

^bi DUKE NUS MEDICAL SCHOOL   (Singapore)

^bj GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^bk Ministry of Health and Welfare   (Taiwan)

^bl Korea Centers for Disease Control and Prevention   (South Korea)

^bm MEDICAL UNIVERSITY OF SILESIA   (Poland)

^bn CHARLES UNIVERSITY   (Czech Republic)

^bo UNIVERSITY OF LEUVEN   (Belgium)

^bp Agency for Preventive   (Austria)

^bq UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^br IRCCS Istituto Neurologico Mediterraneo NEUROMED   (Italy)

^bs INSTITUT PASTEUR DE LILLE   (France)

^bt Instituto de Salud Carlos III   (Spain)

^bu CNR   (Italy)

^bv LILLE UNIVERSITY HOSPITAL   (France)

^bw GHENT UNIVERSITY   (Belgium)

^bx ERASMUS MEDICAL CENTER   (Netherlands)

^by Programme National de Lutte Contre le SIDA   (Côte d’Ivoire)

^bz Cardinal Wyszynski Institute of Cardiology   (Poland)

^ca ROBERT KOCH INSTITUTE   (Germany)

^cb UNIVERSITY OF BENIN   (Nigeria)

^cc University of Benin College of Medical Sciences ^*  (Tunisia)

^cd HOSPITAL DEL MAR   (Spain)

^ce STELLENBOSCH UNIVERSITY   (South Africa)

^cf KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^cg DOKUZ EYLUL UNIVERSITY   (Turkey)

^ch UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^ci Centro de Salud Villanueva Norte   (Spain)

^cj UNIVERSITY OF THE WEST INDIES   (Jamaica)

^ck HOSPITAL DON BENITO VILLANUEVA   (Spain)

^cl National Research Institute on Food and Nutrition   (Italy)

^cm PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^cn UNIVERSITY OF MANCHESTER   (United Kingdom)

^co SCHOOL OF PHYSICS   (Malaysia)

^cp FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^cq HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^cr KYOTO UNIVERSITY   (Japan)

^cs MEDICAL UNIVERSITY OF WARSAW   (Poland)

^ct JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^cu GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^cv CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^cw AUSTRALIAN BUREAU OF STATISTICS   (Australia)

^cx WAGENINGEN UNIVERSITY   (Netherlands)

^cy ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^cz UNIVERSITY OF INSUBRIA   (Italy)

^da UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^db Andes Clinic of Cardio Metabolic Studies   (Venezuela)

^dc INSTITUTO NACIONAL DE HIGIENE   (Cuba)

^dd UNIVERSITY OF ADELAIDE   (Australia)

^de National Center of Cardiovascular Diseases   (China)

^df SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^dg UNIVERSIDAD ICESI   (Colombia)

^dh STATE UNIVERSITY OF MONTES CLAROS   (Brazil)

^di INSTITUTE FOR CLINICAL EFFECTIVENESS AND HEALTH POLICY   (Argentina)

^dj TULANE UNIVERSITY   (United States)

^dk UNIVERSITY OF HONG KONG   (Hong Kong)

^dl CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^dm Heart Institute   (Brazil)

^dn Research Institute of the Fundacion Oftalmologica de Santander FOSCAL   (Colombia)

^do UNIVERSITY OF ORAN   (Algeria)

^dp INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^dq AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^dr CAIRO UNIVERSITY   (Egypt)

^ds NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^dt AGA KHAN UNIVERSITY   (Pakistan)

^du NIIGATA UNIVERSITY   (Japan)

^dv HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^dw UNIVERSITY OF HEIDELBERG   (Germany)

^dx UNIVERSITY OF CRETE   (Greece)

^dy JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^dz National Institute of Epidemiology   (India)

^ea ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^eb SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^ec Research Institute of Child Nutrition   (Germany)

^ed INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^ee National Cancer Center   (South Korea)

^ef KYUSHU UNIVERSITY   (Japan)

^eg INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^eh TARTU UNIVERSITY CLINICS   (Estonia)

^ei NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^ej UNIVERSITY HOSPITAL ULM   (Germany)

^ek MEDICAL UNIVERSITY OF LODZ   (Poland)

^el AFRICAN POPULATION AND HEALTH RESEARCH CENTER   (Kenya)

^em INSTITUT NATIONAL DE SANTÉ PUBLIQUE   (Algeria)

^en MINISTERIO DE SALUD PÚBLICA   (Cuba)

^eo INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^ep UNIVERSITY OF GOTHENBURG   (Sweden)

^eq Food and Agriculture Organization   (Italy)

^er NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^es TAMPERE UNIVERSITY HOSPITAL   (Finland)

^et UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^eu UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^ev INSTITUTO OSWALDO CRUZ   (Brazil)

^ew UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^ex Junta de Castilla y León   (Spain)

^ey UPPSALA UNIVERSITY   (Sweden)

^ez PEKING UNIVERSITY   (China)

^fa JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^fb HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^fc HAROKOPIO UNIVERSITY   (Greece)

^fd UNIVERSITY OF PADOVA   (Italy)

^fe LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^ff SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^fg CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^fh UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^fi BROWN UNIVERSITY   (United States)

^fj UNIVERSITY OF EDINBURGH   (United Kingdom)

^fk UNIVERSITY COLLEGE DUBLIN   (Ireland)

^fl INSERM   (France)

^fm AIN SHAMS UNIVERSITY   (Egypt)

^fn UNIVERSITY OF PÉCS   (Hungary)

^fo MULAGO HOSPITAL   (Uganda)

^fp UNIVERSITY OF ZARAGOZA   (Spain)

^fq PERDANA UNIVERSITY   (Malaysia)

^fr INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^fs UNIVERSITY OF BRESCIA   (Italy)

^ft INSTITUTE OF EPIDEMIOLOGY   (Germany)

^fu UNIVERSITY OF EASTERN FINLAND   (Finland)

^fv UNIVERSITY OF ULM   (Germany)

^fw Suraj Eye Institute   (India)

^fx University of Medicine and Pharmacy   (Viet Nam)

^fy UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^fz UNIVERSITY OF BARI   (Italy)

^ga Federal Ministry of Health   (Bosnia and Herzegovina)

^gb UNIVERSITY OF NEW SOUTH WALES   (Australia)

^gc Public Health Agency of Catalonia   (Spain)

^gd AL QUDS UNIVERSITY   (Palestine)

^ge ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^gf UNIVERSITY OF TURKU   (Finland)

^gg INSTITUT UNIVERSITARI D'INVESTIGACIÓ EN ATENCIÓ PRIMÀRIA JORDI GOL   (Spain)

^gh UNIVERSITY OF MALAYA   (Malaysia)

^gi LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^gj UNIVERSITY OF VALENCIA   (Spain)

^gk UNIVERSITY OF THE PHILIPPINES   (Philippines)

^gl Health Center San Agustin   (Spain)

^gm PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^gn UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^go INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^gp CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^gq UNIVERSITY OF MADEIRA   (Portugal)

^gr Sitaram Bhartia Institute of Science Research   (India)

^gs MARMARA UNIVERSITY   (Turkey)

^gt UNIVERSITY OF HELSINKI   (Finland)

^gu NATIONAL INSTITUTES OF HEALTH   (United States)

^gv UNIVERSITY OF SÃO PAULO   (Brazil)

^gw UNIVERSITY OF LISBON   (Portugal)

^gx HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^gy UNIVERSITY OF TOKYO   (Japan)

^gz FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^ha ST VINCENT S HOSPITAL   (Australia)

^hb KAROLINSKA INSTITUTE   (Sweden)

^hc LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^hd LUND UNIVERSITY   (Sweden)

^he UNIVERSITÉ DE BORDEAUX   (France)

^hf UNIVERSITY OF BONN   (Germany)

^hg NATIONAL INSTITUTE OF HYGIENE   (Poland)

^hh FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^hi Ministry of Health   (Jordan)

^hj Area de Salut de Menorca   (Spain)

^hk INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^hl MINISTRY OF HEALTH   (New Zealand)

^hm ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^hn MEDICAL UNIVERSITY OF VIENNA   (Austria)

^ho UNIVERSITY OF OXFORD   (United Kingdom)

^hp Institute of Food Nutrition Development of Ministry of Agriculture   (China)

^hq CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^hr UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^hs Center for Diabetes and Endocrine Care   (India)

^ht MEHARRY MEDICAL COLLEGE   (United States)

^hu ACADEMIC MEDICAL CENTER   (Netherlands)

^hv Centro Per la Prevenzione Cardiovascolare   (Italy)

^hw Departamento de Salud Pública   (Spain)

^hx FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^hy MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^hz UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^ia UNIVERSITÉ DE STRASBOURG   (France)

^ib UNIVERSITY COLLEGE CORK   (Ireland)

^ic INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^id CAPITAL MEDICAL UNIVERSITY   (China)

^ie MINISTRY OF HEALTH   (Seychelles)

^if UNIVERSITY OF GREENLAND   (Greenland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

AGE; ARTICLE; BODY MASS; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; ECONOMIC ASPECT; FALSE POSITIVE RESULT; FEMALE; GEOGRAPHY; GLUCOSE BLOOD LEVEL; GROSS NATIONAL PRODUCT; HEALTH SURVEY; HIGH INCOME REGION; HUMAN; INCOME; MALE; ORAL GLUCOSE TOLERANCE TEST; POPULATION GROUP; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ADULT; BLOOD; GLUCOSE TOLERANCE TEST; HEALTH; METABOLISM; SENTINEL SURVEILLANCE;

ADULT; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FEMALE; GLOBAL HEALTH; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PREVALENCE; SENSITIVITY AND SPECIFICITY; SENTINEL SURVEILLANCE;

EID: 84938199196     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00129-1     Document Type: Article

References (103)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011, 378:31-40.
2. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet 2011, 377:557-567.
3. Stevens GA, Singh GM, Lu Y, et al. National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr 2012, 10:22.
4. Kontis V, Mathers CD, Rehm J, et al. Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study. Lancet 2014, 384:427-437.
5. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014, 2:634-647. Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration.
6. Zimmet PZ, Magliano DJ, Herman WH, Shaw JE Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2014, 2:56-64.
7. Yach D, Stuckler D, Brownell KD Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 2006, 12:62-66.
8. IDF Diabetes Atlas 2013, International Diabetes Federation, International Diabetes Federation, Brussels. 6th edn.
9. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus 1999, WHO, World Health Organization, Geneva.
10. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation 2006, WHO, World Health Organization, Geneva.
11. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation 2011, WHO, World Health Organization, Geneva.
12. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26 (suppl 1):S5-S20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
13. Standards of medical care in diabetes-2014. Diabetes Care 2014, 37 (suppl 1):S14-S80. American Diabetes Association.
14. Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37 (suppl 1):S81-S90. American Diabetes Association.
15. Barrett-Connor E The oral glucose tolerance test, revisited. Eur Heart J 2002, 23:1229-1231.
16. Tobias M Global control of diabetes: information for action. Lancet 2011, 378:3-4.
17. Hare MJ, Shaw JE, Zimmet PZ Current controversies in the use of haemoglobin A1c. J Intern Med 2012, 271:227-236.
18. Global action plan for the prevention and control of non-communicable diseases 2013-2020 2013, WHO, World Health Organization, Geneva.
19. Shibata K, Suzuki S, Sato J, et al. Diagnostic accuracy of glycohemoglobin A1c (HbA1c) for postprandial hyperglycemia was equivalent to that of fasting blood glucose. J Clin Epidemiol 2005, 58:1052-1057.
20. Kim HK, Bae SJ, Choe J Impact of HbA1c criterion on the detection of subjects with increased risk for diabetes among health check-up recipients in Korea. Diabetes Metab J 2012, 36:151-156.
21. Mo M, Zhong W, Zhao G, et al. Combining glycosylated hemoglobin A1c and fasting plasma glucose for diagnosis of type 2 diabetes in Chinese adults. BMC Endocr Disord 2013, 13:44.
22. Wiener K, Roberts NB The relative merits of haemoglobin A1c and fasting plasma glucose as first-line diagnostic tests for diabetes mellitus in non-pregnant subjects. Diabet Med 1998, 15:558-563.
23. Vlaar EM, Admiraal WM, Busschers WB, et al. Screening South Asians for type 2 diabetes and prediabetes: (1) comparing oral glucose tolerance and haemoglobin A1c test results and (2) comparing the two sets of metabolic profiles of individuals diagnosed with these two tests. BMC Endocr Disord 2013, 13:8.
24. Mannucci E, Ognibene A, Sposato I, et al. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2003, 40:181-186.
25. Carson AP, Reynolds K, Fonseca VA, Muntner P Comparison of A1C and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care 2010, 33:95-97.
26. Adamu AN Comparative performance of HbA1c 6.5% for FPG >/=7.0 vs 2hr PG>/=11.1 criteria for diagnosis of type 2 diabetes. Afr Health Sci 2011, 11:421-426.
27. Cederberg H, Saukkonen T, Laakso M, et al. Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study. Diabetes Care 2010, 33:2077-2083.
28. Kramer CK, Araneta MR, Barrett-Connor E A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care 2010, 33:101-103.
29. Li HY, Ma WY, Wei JN, et al. Hemoglobin A1c for the diagnosis of diabetes: To replace or to guide oral glucose tolerance tests?. J Diabetes Investig 2012, 3:259-265.
30. Pajunen P, Peltonen M, Eriksson JG, et al. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study. Diabet Med 2011, 28:36-42.
31. Piette JD, Milton EC, Aiello AE, Mendoza-Avelares MO, Herman WH Comparison of three methods for diabetes screening in a rural clinic in Honduras. Rev Panam Salud Publica 2010, 28:49-57.
32. Pinelli NR, Jantz AS, Martin ET, Jaber LA Sensitivity and specificity of glycated hemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 2011, 96:E1680-E1683.
33. Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011, 34:84-89.
34. Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria. Diabetes Care 2010, 33:2184-2189.
35. Almoosawi S, Cole D, Nicholson S, et al. Biomarkers of diabetes risk in the National Diet and Nutrition Survey rolling programme (2008-2011). J Epidemiol Community Health 2014, 68:51-56.
36. Droumaguet C, Balkau B, Simon D, et al. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2006, 29:1619-1625.
37. Engelgau MM, Thompson TJ, Herman WH, et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 1997, 20:785-791.
38. Hjellestad ID, Astor MC, Nilsen RM, Softeland E, Jonung T HbA(1)c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients. Cardiovasc Diabetol 2013, 12:79.
39. Hu YM, Liu W, Chen YW, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010, 47:231-236.
40. Balkau B, Soulimane S, Lange C, et al. Are the same clinical risk factors relevant for incident diabetes defined by treatment, fasting plasma glucose, and HbA1c?. Diabetes Care 2011, 34:957-959.
41. Soulimane S, Simon D, Shaw J, et al. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diabetes Res Clin Pract 2012, 96:392-399.
42. Soulimane S, Simon D, Shaw JE, et al. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies. Diabet Med 2011, 28:1311-1318.
43. de Vegt F, Dekker JM, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study. Diabetes Care 2000, 23:40-44.
44. Wild SH, Smith FB, Lee AJ, Fowkes FG Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort. Diabet Med 2005, 22:490-496.
45. Zhang YH, Ma WJ, Thomas GN, et al. Diabetes and pre-diabetes as determined by glycated haemoglobin A1c and glucose levels in a developing southern Chinese population. PLoS One 2012, 7:e37260.
46. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 2010, 33:562-568.
47. Ito C, Maeda R, Ishida S, Sasaki H, Harada H Correlation among fasting plasma glucose, two-hour plasma glucose levels in OGTT and HbA1c. Diabetes Res Clin Pract 2000, 50:225-230.
48. Kharroubi AT, Darwish HM, Abu Al-Halaweh AI, Khammash UM Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population. PLoS One 2014, 9:e88123.
49. Bao Y, Ma X, Li H, et al. Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey. BMJ 2010, 340:c2249.
50. Davidson MB Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care 2011, 34:524-526.
51. Nazir A, Papita R, Anbalagan VP, Anjana RM, Deepa M, Mohan V Prevalence of diabetes in Asian Indians based on glycated hemoglobin and fasting and 2-H post-load (75-g) plasma glucose (CURES-120). Diabetes Technol Ther 2012, 14:665-668.
52. Rathmann W, Kowall B, Tamayo T, et al. Hemoglobin A1c and glucose criteria identify different subjects as having type 2 diabetes in middle-aged and older populations: The KORA S4/F4 Study. Ann Med 2012, 44:170-177.
53. Blunt BA, Barrettconnor E, Wingard DL Evaluation of fasting plasma-glucose as screening-test for Niddm in older adults-Rancho Bernardo Study. Diabetes Care 1991, 14:989-993.
54. Nakagami T, Tominaga M, Nishimura R, et al. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007, 76:251-256.
55. Munera-Jaramillo MI, Restrepo-Lozada MA, Gomez-Bahamon LM, Mesa-Suarez Ddel R, Ramirez-Puerta BS Glycosylated haemoglobin A1c compared to fasting plasma glucose in outpatients referred to a medical laboratory. Rev Salud Publica (Bogota) 2011, 13:980-989. (in Spanish).
56. Araneta MR, Grandinetti A, Chang HK A1C and diabetes diagnosis among Filipino Americans, Japanese Americans, and Native Hawaiians. Diabetes Care 2010, 33:2626-2628.
57. Homko CJ, Zamora LC, Kerper MM, Mozzoli M, Kresge K, Boden G A single a1c >= 6.5% accurately identifies type 2 diabetes/impaired glucose tolerance in African Americans. J Prim Care Community Health 2012, 3:235-238.
58. Khoo J, Tay TL, Foo JP, et al. Sensitivity of A1C to diagnose diabetes is decreased in high-risk older Southeast Asians. J Diabetes Complications 2012, 26:99-101.
59. Peter A, Fritsche A, Stefan N, Heni M, Haring HU, Schleicher E Diagnostic value of hemoglobin A1c for type 2 diabetes mellitus in a population at risk. Exp Clin Endocrinol Diabetes 2011, 119:234-237.
60. van 't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 2010, 33:61-66.
61. Lipska KJ, De Rekeneire N, Van Ness PH, et al. Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c. J Clin Endocrinol Metab 2010, 95:5289-5295.
62. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998, 317:371-375. DECODE Study Group.
63. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003, 26:61-69. DECODE Study Group.
64. Qiao Q, Hu G, Tuomilehto J, et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003, 26:1770-1780.
65. Shaw JE, de Courten M, Boyko EJ, Zimmet PZ Impact of new diagnostic criteria for diabetes on different populations. Diabetes Care 1999, 22:762-766.
66. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 1999, 42:647-654. DECODE Study Group.
67. Christensen DL, Witte DR, Kaduka L, et al. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010, 33:580-582.
68. Ziemer DC, Kolm P, Weintraub WS, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010, 152:770-777.
69. Kumar PR, Bhansali A, Ravikiran M, et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab 2010, 95:2832-2835.
70. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 2011, 154:303-309.
71. Implications of the Diabetes Control and Complications Trial. Diabetes Care 2000, 23 (suppl 1):S24-S26. American Diabetes Association.
72. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009, 32:287-294.
73. Schwarz G Estimating dimension of a model. Ann Stat 1978, 6:461-464.
74. Di Cesare M, Khang YH, Asaria P, et al. Inequalities in non-communicable diseases and effective responses. Lancet 2013, 381:585-597.
75. Cohen J, Cohen P, West SG, Aiken LS Applied multiple regression/correlation analysis for the behavioral sciences 2013, Routledge.
76. DerSimonian R, Laird N Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
77. Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2011, 57:e1-e47.
78. Snijders TAB, Bosker RJ Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling 2011, SAGE Publications.
79. Nakagawa S, Schielzeth H A general and simple method for obtaining R2 from generalized linear mixed-effects models. Methods Ecol Evol 2013, 4:133-142.
80. Qiao Q, Tuomilehto J, Balkau B, et al. Are insulin resistance, impaired fasting glucose and impaired glucose tolerance all equally strongly related to age?. Diabet Med 2005, 22:1476-1481.
81. Zamboni M, Armellini F, Harris T, et al. Effects of age on body fat distribution and cardiovascular risk factors in women. Am J Clin Nutr 1997, 66:111-115.
82. Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health 2013, 1:e16-e25.
83. Colagiuri S, Lee CM, Wong TY, et al. Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. Diabetes Care 2011, 34:145-150.
84. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 2014, 311:1225-1233. Emerging Risk Factors Collaboration.
85. Hare MJ, Magliano DJ, Zimmet PZ, et al. Glucose-independent ethnic differences in HbA1c in people without known diabetes. Diabetes Care 2013, 36:1534-1540.
86. Choi SH, Kim TH, Lim S, Park KS, Jang HC, Cho NH Hemoglobin A1c as a diagnostic tool for diabetes screening and new-onset diabetes prediction: a 6-year community-based prospective study. Diabetes Care 2011, 34:944-949.
87. Lee H, Oh JY, Sung YA, et al. Optimal hemoglobin A1C cutoff value for diagnosing type 2 diabetes mellitus in Korean adults. Diabetes Res Clin Pract 2013, 99:231-236.
88. Nomura K, Inoue K, Akimoto K A two-step screening, measurement of HbA1c in association with FPG, may be useful in predicting diabetes. PLoS One 2012, 7:e36309.
89. Kim JM, Hong JW, Won JC, et al. Glycated hemoglobin value for fasting plasma glucose of 126 mg/dL in Korean: The 2011 Korea National Health and Nutrition Examination Survey. Diabetes Metab J 2014, 38:480-483.
90. Son JI, Rhee SY, Woo JT, et al. Hemoglobin a1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J 2013, 37:343-348.
91. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
92. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
93. Little RR Glycated hemoglobin standardization-National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med 2003, 41:1191-1198.
94. Hoelzel W, Weykamp C, Jeppsson JO, et al. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 2004, 50:166-174.
95. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007, 50:2042-2043. American Diabetes Association, European Association for the Study of DiabetesEuropean Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory MedicineInternational Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes FederationInternational Diabetes Federation.
96. Hanas R, John G 2010 consensus statement on the worldwide standardization of the hemoglobin A1c measurement. Diabet Med 2010, 27:737-738.
97. Hanas R, John WG 2013 update on the worldwide standardization of the HbA1c measurement. Diabet Med 2013, 30:885-886.
98. International Federation of Clinical Chemistry (IFCC) Standardization of HbA1c National Glycohemoglobin Standardization Program, (accessed Dec 29, 2014). http://www.ngsp.org/docs/IFCCstd.pdf.
99. Simon D, Senan C, Balkau B, Saint-Paul M, Thibult N, Eschwege E Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care 1999, 22:1361-1363.
100. Little RR, Rohlfing CL, Sacks DB Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem 2011, 57:205-214.
101. Hardikar PS, Joshi SM, Bhat DS, et al. Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia. Diabetes Care 2012, 35:797-802.
102. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999, 354:617-621. DECODE study group.
103. Nakagami T Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004, 47:385-394. DECODA Study Group.